Dexcom (DXCM) Stock Price & AI Analysis

$85.67
-$0.85
(0.98%)
Health Care Equipment

NASDAQ USA

May 16, 5:37 PM EDT
  • Market Cap.
    33.59B
  • Volume
    2.89M
  • Avg. Volume
    4.58M
  • Target Price
    $99.08
  • 52W Range
    57.52 - 132.26
  • RSI (14)
    69.05
  • Beta
    1.47
  • PEG Ratio
    2.69
  • SMA 20
    11.80%
  • SMA 50
    18.44%
  • SMA 200
    13.79%
  • Insider Owner
    1.42%
  • Insider Trans
    -2.52%
  • Institution Owner
    94.46%
  • Institution Trans
    -1.23%
  • Short Interest
    11.41%
  • EPS next Y
    25.74

Dexcom Company Profile

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom | Latest news

DXCM Q1 Earnings Call: Coverage Expansion and Product Pipeline Shape 2025...

Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q1 CY2025,...

StockStory - 1 day ago

Here's Why You Should Add DexCom Stock to Your Portfolio Now

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product...

Zacks - 10 hours ago

All You Need to Know About DexCom (DXCM) Rating Upgrade to Buy

DexCom (DXCM) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy)....

Zacks - 4 days ago

DexCom, Inc. (NASDAQ:DXCM) Receives $98.11 Consensus PT from Brokerages

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty brokerages that are presently covering the stock, MarketBeat.com reports ...

ETF DAILY NEWS - 19 hours ago

The 12.44% Simple Moving Average of Dexcom Inc’s (DXCM) Stock in the Past 200...

The stock of Dexcom Inc (DXCM) has seen a 3.56% increase in the past week, with a 27.65% gain in the past month, and a -2.26% decrease in the past quarter. The volatility ratio for the week ...

NewsHeater - 4 days ago

The Zacks Analyst Blog Highlights Sprouts Farmers Market, DexCom, Hims & Hers...

Stocks recently featured in the blog include: Sprouts Farmers Market Inc. SFM, DexCom Inc. DXCM,...

Zacks - 3 days ago

ALGN Stock Might Rise Following the NMPA Approval in China

Some other top-ranked stocks in the broader medical space are AngioDynamics ANGO, STERIS STE and...

Zacks - 10 hours ago

5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil

We have selected five such stocks that have provided double-digit returns in the past month during...

Zacks - 1 day ago

Top Health & Fitness Stocks to Buy for the Wellness Boom

The health and fitness boom is fueling demand for gyms, nutrition, and wellness services. Stocks...

Zacks - 2 days ago

Billionaire Ken Griffin’s 10 Midcap Stock Picks with Huge Upside Potential

Ken Griffin, the founder of Citadel, is an influential albeit controversial figure in the investment...

Insider Monkey - 3 days ago